Drug · DIN 02530708
APIXABAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 7, 2026; first marketed November 1, 2022.
- Drug Identification Number (DIN)
- 02530708
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Apixaban B01AF02
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| APIXABAN | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 7, 2026: NOC 38065Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
- September 20, 2022: NOC 29023Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
Other DINs named APIXABAN
- DIN 02530716 · Marketed
- DIN 02548879 · Marketed
- DIN 02548887 · Marketed